Medical Testing

How concerning are links of blood clots to AstraZeneca's vaccine?

Fri, 2021-04-09 19:43 — mike kraft

How worried should we be about links of blood clots to AstraZeneca's vaccine? Europe's drug regulator on Wednesday said it had found a possible link between AstraZeneca's COVID-19 vaccine and very rare blood clots in adults who received the shot. Britain recommended people under 30 get an alternative COVID-19 vaccine if possible. John Miller, Ludwig Burger U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about How concerning are links of blood clots to AstraZeneca's vaccine?
Log in or register to post comments

FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says

Fri, 2021-04-09 19:11 — mike kraft

FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says It’s “highly likely” the US Food and Drug Administration will allow Pfizer’s Covid-19 vaccine to be used in children aged 12 to15, according to the acting chairman of an FDA vaccine advisory committee. By <a href="/profiles/julia-hollingsworth">Julia Hollingsworth</a>, Melissa Macaya, <a href="/profiles/melissa-mahtani">Melissa Mahtani</a>, <a href="/profiles/veronica-rocha">Veronica Rocha</a> and <a href="/profiles/fernando-alfonso-iii">Fernando Alfonso III</a>, CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says
Log in or register to post comments

NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines

Wed, 2021-04-07 17:55 — mike kraft

New NIH study to gauge risk of allergic reactions to Pfizer, Moderna The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals. Justine Coleman TheHill

The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines
Log in or register to post comments

AstraZeneca: Researchers race to understand why handful of patients develop blot clots

Wed, 2021-04-07 10:07 — mike kraft

Europe’s vaccine divide: As scientists scramble for answers to AstraZeneca blood clot puzzle, some nations opt for caution The cases of brain clots remain very rare. That is just one challenge for researchers. Loveday Morris Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca: Researchers race to understand why handful of patients develop blot clots
Log in or register to post comments

Six months later, a third of COVID-19 patients have been diagnosed psychiatric or neurological illness

Wed, 2021-04-07 09:27 — mike kraft

1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition Six months after being diagnosed with Covid-19, 1 in 3 patients had also experienced a neuropsychiatric illness. Elizabeth Cooney STAT

Six months after being diagnosed with Covid-19, 1 in 3 patients also had experienced a psychiatric or neurological illness, mostly mood disorders but also strokes or dementia, a large new study shows.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

AstraZeneca developments: Oxford suspends trial with children, European official says casual link with rare blot cots

Tue, 2021-04-06 18:37 — mike kraft

Oxford halts AstraZeneca COVID-19 vaccinations in kids' trial The University of Oxford has suspended AstraZeneca COVID-19 vaccinations in a small clinical trial for children, while the U.K.’s medicines regulator examines reports of rare blood clotting in vaccinated adults. Kayla Rivas Fox News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Researchers Are starting Clinical Trials on a New Type Low-Cost Coronavirus Vaccine

Mon, 2021-04-05 12:41 — mike kraft

A new vaccine for Covid-19 that is entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. The vaccine, called NVD-HXP-S, is the first in clinical trials to use a new molecular design that is widely expected to create more potent antibodies than the current generation of vaccines. And the new vaccine could be far easier to make.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Researchers Are starting Clinical Trials on a New Type Low-Cost Coronavirus Vaccine
Log in or register to post comments

UK eyes mass testing, overview of other developments

Mon, 2021-04-05 11:59 — mike kraft

UK eyes mass testing as it takes next steps out of lockdown LONDON (AP) — All adults and children in England will be able to have routine coronavirus tests twice a week as a way to stamp out new outbreaks, the British government said Monday as it prepared... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK eyes mass testing, overview of other developments
1 comment
Log in or register to post comments

Early trials begin of Moderna vaccine against South African variant

Thu, 2021-04-01 10:06 — mike kraft

NIH begins early trials of Moderna vaccine against South African The National Institutes of Health has begun early-stage clinical trials of an investigational coronavirus vaccine from Moderna intended to protect against a strain of the virus first discovered in Nathaniel Weixel TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Early trials begin of Moderna vaccine against South African variant
Log in or register to post comments

FDA Approves 2 Rapid COVID Tests for at home use

Thu, 2021-04-01 09:30 — mike kraft

More consumers will soon be able to test themselves for COVID-19 from the comfort of their own home. On Wednesday, the Food and Drug Administration approved two rapid antigen home tests for use in the U.S.

Americans will soon be able to purchase Abbott's BinaxNOW and Quidel Quickvue tests at drug stores. The two options join a test made by Ellume, which received FDA approval in December, in the market. The two, newly-approved swab tests will be sold at a lower price point.

The BinaxNOW and Quickvue tests are expected to be sold in two-packs for around $15-20; Ellume costs $30.

Country / Region Tags:

General Topic Tags: